Association of genetic polymorphisms in VEGF ‐460, ‐7 and ‐583 and hematocrit level with the development of idiopathic recurrent pregnancy loss and a meta‐analysis
- 30 August 2018
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 20 (9) , e3048
Abstract
Background: The present study was performed to investigate whether genetic variants of VEGF are associated with recurrent pregnancy loss (RPL) in Korean women and to provide insight into the role of VEGF in the pathogenesis of RPL development.Methods: A cohort of 384 women with idiopathic RPL with a history of two or more uxexplained consecutive early pregnancy losses and 236 control women were recruited from an infertility center of university‐teaching hospital in Korea between March 1999 and February 2010. We examined three VEGF polymorphisms (rs833061, rs3025020 and rs25648). Genotyping was assessed by polymerase chain reaction (PCR)‐restriction fragment length polymorphism analyses (rs3025020) or real‐time PCR (rs833061, rs25648).Results: There was no statistically significant difference in frequency of each three VEGF polymorphic loci between the control and RPL groups. Allele combinations of VEGF rs3025020/rs833061 TT/TC and TT/TC + CC genotypes were associated with an increased frequency of RPL development [odds ratio (OR) = 3.525, 95% confidence interval (CI) = 1.154–10.767, p = 0.027 and OR = 3.815, 95% CI = 1.256–11.588, p = 0.018, respectively]. Haplotype analysis revealed that two allele combinations (rs833061/rs3025020 C‐T and rs25648/rs3025020 T‐T) were associated with an increased prevalence of RPL (OR = 2.548, 95% CI = 1.502–4.320, p = 0.0004 and OR = 16.50, 95% CI = 0.976–278.8, p = 0.003, respectively). Allele combinations and haplotypes of rs3025020/rs833061 were associated with maternal blood hematocrit (HCT) levels in the RPL group (p = 0.048 and 0.006, respectively).Conclusions: The VEGF rs833061/rs3025020 genotype allele was related to the development of RPL and was also associated with maternal blood HCT levels in RPL patients. However, further studies are needed to clarify the exact mechanism of how VEGF and HCT are involved in RPL development.Keywords
Funding Information
- Korea Health Industry Development Institute (HI15C1972010015)
- National Research Foundation of Korea (NRF-2015R1D1A1A09057432, NRF-2014R1A2A2 A01003994)
This publication has 23 references indexed in Scilit:
- Identification of Key Contributory Factors Responsible for Vascular Dysfunction in Idiopathic Recurrent Spontaneous MiscarriagePLOS ONE, 2013
- An Increase in Vascular Endothelial Growth Factor (VEGF) and VEGF Soluble Receptor-1 (sFlt-1) Are Associated with Early Recurrent Spontaneous AbortionPLOS ONE, 2013
- Maintenance Bevacizumab is Associated With Increased Hemoglobin in Patients With Advanced, Nonsquamous, Non-Small Cell Lung CancerCancer Investigation, 2012
- Genetics of VEGF Serum Variation in Human Isolated Populations of Cilento: Importance of VEGF PolymorphismsPLOS ONE, 2011
- Association study of vascular endothelial growth factor polymorphisms with the risk of recurrent spontaneous abortionFertility and Sterility, 2010
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter StudyJournal of Clinical Oncology, 2009
- Increased Hemoglobin Associated with VEGF Inhibitors in Advanced Renal Cell CarcinomaCancer Investigation, 2009
- Expression of angiogenesis‐ and apoptosis‐related genes in chorionic villi derived from recurrent pregnancy loss patientsMolecular Reproduction and Development, 2003
- Recurrent miscarriage.BMJ, 1991
- Recurrent miscarriage I: definition and epidemiologyThe Lancet, 1990